CAPITA1
HomeIPONewsBlogCommodities
CAPITA1
Disclaimer

No financial information whatsoever published anywhere within this application should be considered as advice to buy or sell securities, invest in IPOs, or make any investment decisions. All content is provided solely for educational and informational purposes.

We are not a SEBI-registered analyst or investment advisor. Users should consult a qualified financial advisor before making any investment decisions based on information available on this application.

The information presented in this application is based on publicly available data, market perceptions, and sources believed to be reliable at the time of publication. We do not guarantee the accuracy, completeness, or timeliness of the information.

By using this application, you acknowledge and agree to these terms and conditions.

Terms of UsePrivacy PolicyDisclaimerContact UsAbout Us
Follow CAPITA1
© 2026 CAPITA1. All Rights Reserved.
IPO Center
Molbio Diagnostics logo

Molbio Diagnostics

UpcomingMainboard

— · — · —

Last updated: 04 Aug 2026, 03:54 pm · 35m ago
IPO Snapshot
0/ 100
Opportunity Score
Valuation N/A
Broker Consensus
Avoid
GMP %
+0.00%
Subscription
N/A
P/E
N/A
ROE
N/A
ROCE
N/A
DRHP RHP — N/A

“Broker Consensus” is CAPITA1's algorithmic verdict from GMP, subscription, fundamentals & valuation — broker recommendations aren't in our data feed. GMP is an unofficial grey-market estimate. Not investment advice.

🏢 Know the CompanyAI

Valuation (at Upper Band)

Not Available — valuation needs EPS / financials, which aren't available for this IPO yet.

AI IPO AnalysisAI

DRHP / RHP IntelligenceAI

Generate an AI read of the offer document — business, risks, promoters, use of funds and an educational verdict, with citations back into the filing.

Company Overview

Molbio Diagnostics IPO date is August 10, 2026. Check Molbio Diagnostics IPO review, price, lot size, financial results, valuations & more details.

GMP (Grey Market Premium)

₹0+0.00%

IPO Watch (grey market, unofficial) — not investment advice. Updated 04 Aug 2026, 03:54 pm.

Subscription

Bidding not started.

Timeline

Open Date
10 Aug 2026
Close Date
12 Aug 2026
Allotment
13 Aug 2026
Refund
14 Aug 2026
Demat Credit
14 Aug 2026
Listing
17 Aug 2026

Lot Size & Offer

Lot Size
Not Available
Min Investment
Not Available
Fresh Issue
Not Available
Offer for Sale
Not Available

Reservation

QIB
50%
NII / HNI
15%
Retail
35%
Employee
Not Available

Objectives of the Issue

  • Funding capital expenditure towards the setting up of infrastructure for our research and development facility, Center of Excellence and connected office space.
  • Funding capital expenditure towards the purchase of certain plant, machinery and other equipment for Goa Unit I, Goa Unit II and Visakhapatnam Unit, and
  • General corporate purposes

Financial Highlights (₹ Cr)

Not Available

Revenue Growth
Not Available
PAT Growth
Not Available
EBITDA
Not Available
EBITDA Margin
22.56%
ROE
15.59%
ROCE
17.55%
Debt / Equity
Not Available
Net Worth
Not Available

Promoter Holding

Pre-Issue
Not Available
Post-Issue
Not Available

Registrar & Managers

Registrar
Purva Sharegistry (India) Pvt. Ltd.
Market Maker
Hem Finlease Pvt. Ltd.
Book Running Lead Managers
Not Available

Offer Documents

DRHP RHP — Not Available

Market data: NSE (official calendar + subscription) · IPO Watch (unofficial GMP + discovery) · updated 04 Aug 2026, 03:54 pm

Fundamentals: IPO Watch (ipowatch.in) · fetched 04 Aug 2026, 03:54 pm

IPO calendar and subscription from NSE. GMP is an unofficial grey-market estimate (IPO Watch) — not investment advice. Company fundamentals (financials, peers) are not part of the live feed.